Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of Neurochemistry|July 1, 1985
High- and low-affinity binding components for [3H]imipramine in rat cerebral cortexP G Conway, D J BrunswickThe Journal of Pharmacology and Experimental Therapeutics|October 1, 1985
Labeling in vivo of beta adrenergic receptors in the central nervous system of the rat after administration of [125I] iodopindololL Tondo, P G Conway, D J BrunswickNeuropharmacology|October 1, 1991
Effect of ritanserin on the interaction of amfonelic acid and neuroleptic-induced striatal dopamine metabolismL R Brougham, P G Conway, D B EllisThe Journal of Pharmacology and Experimental Therapeutics|June 1, 1987
Interaction of beta adrenergic agonists and antagonists with brain beta adrenergic receptors in vivoP G Conway, S Tejani-Butt, D J BrunswickThe Journal of Pharmacology and Experimental Therapeutics|August 1, 1996
Ex vivo studies with iloperidone (HP 873), a potential atypical antipsychotic with dopamine D2/5-hydroxytryptamine2 receptor antagonist activityA M Szczepanik, L R Brougham, J E Roehr, et al.The Journal of Pharmacology and Experimental Therapeutics|September 1, 1995
The pharmacological profile of iloperidone, a novel atypical antipsychotic agentM R Szewczak, R Corbett, D K Rush, et al.The Journal of Pharmacology and Experimental Therapeutics|February 11, 1991
Cardiac adenylate cyclase activity, positive chronotropic and inotropic effects of forskolin analogs with either low, medium or high binding site affinityJ W Hubbard, P G Conway, L C Nordstrom, et al.Journal of Medicinal Chemistry|July 22, 1994
Benzisoxazole- and benzisothiazole-3-carboxamides as potential atypical antipsychotic agentsN J Hrib, J G Jurcak, K L Burgher, et al.Journal of Medicinal Chemistry|March 31, 1995
3-[[(Aryloxy)alkyl]piperidinyl]-1,2-benzisoxazoles as D2/5-HT2 antagonists with potential atypical antipsychotic activity: antipsychotic profile of iloperidone (HP 873)J T Strupczewski, K J Bordeau, Y Chiang, et al.Pageof 1